Key Takeaways
- • The Private Equity Stakeholder Project (PESP) has expanded its state healthcare policy tracker to document 79 bills across 25 states, representing a 43% increase from the previous dataset with 34 additional bills added in this update.
- • Sixteen new bills were introduced across ten states during January and February 2026 alone, demonstrating sustained legislative momentum addressing private equity and investor-backed ownership in healthcare.
- • Primary policy approaches under consideration include transparency and reporting requirements mandating disclosure of ownership structures and financial relationships, and expanded regulatory approval and enforcement authority for state attorneys general over healthcare mergers and acquisitions.
- • Legislative focus has been driven by documented concerns including hospital closures, healthcare provider bankruptcies, rising healthcare costs, and the proliferation of investor-backed firms across multiple healthcare segments.
- • The expansion incorporates 18 previously unidentified bills from 2025, indicating that state-level scrutiny of private equity in healthcare has been more extensive than initially tracked.
Summary
State legislatures across the United States are intensifying regulatory scrutiny of private equity involvement in healthcare, with the Private Equity Stakeholder Project documenting unprecedented legislative activity in this sector. The updated PESP state healthcare policy tracker now identifies 79 bills across 25 states, a significant expansion from prior counts. The most recent update adds 34 bills to the tracker, including 16 introduced in ten states during the first two months of 2026, alongside 18 additional bills from 2025 that were identified during this expansion phase.
The legislative proposals cluster around two principal policy approaches. First, transparency and reporting requirements aim to mandate disclosure of ownership structures and financial relationships within healthcare entities, addressing information asymmetries that have characterized prior private equity healthcare transactions. Second, approval and enforcement authority measures expand the regulatory powers of state officials—particularly state attorneys general—to review, condition, or block healthcare mergers, acquisitions, and ownership changes. This second approach represents a significant shift toward gatekeeping mechanisms that did not exist in prior regulatory frameworks.
Policymaker concerns underpinning this legislative wave reflect documented operational and financial pressures within the healthcare system. According to PESP's 2025 State Healthcare Policy Review, legislators cite hospital closures, healthcare provider bankruptcies, rising costs, and the growing presence of investor-backed ownership structures across healthcare delivery segments as primary drivers of proposed regulation. These concerns transcend traditional geographic or political divides, with activity documented across 25 distinct state jurisdictions.
The pace of bill introduction accelerated notably in early 2026, with 16 bills introduced in just two months, suggesting that regulatory momentum is building rather than plateauing. This legislative activity reflects broader skepticism about private equity ownership models in essential healthcare services, where financial optimization pressures may conflict with continuity of care and affordability objectives. The breadth of coverage—spanning 25 states with multiple bills per state in many cases—indicates that healthcare private equity regulation has transitioned from isolated initiatives to a coordinated policy focus across state legislatures.
The legislative proposals cluster around two principal policy approaches. First, transparency and reporting requirements aim to mandate disclosure of ownership structures and financial relationships within healthcare entities, addressing information asymmetries that have characterized prior private equity healthcare transactions. Second, approval and enforcement authority measures expand the regulatory powers of state officials—particularly state attorneys general—to review, condition, or block healthcare mergers, acquisitions, and ownership changes. This second approach represents a significant shift toward gatekeeping mechanisms that did not exist in prior regulatory frameworks.
Policymaker concerns underpinning this legislative wave reflect documented operational and financial pressures within the healthcare system. According to PESP's 2025 State Healthcare Policy Review, legislators cite hospital closures, healthcare provider bankruptcies, rising costs, and the growing presence of investor-backed ownership structures across healthcare delivery segments as primary drivers of proposed regulation. These concerns transcend traditional geographic or political divides, with activity documented across 25 distinct state jurisdictions.
The pace of bill introduction accelerated notably in early 2026, with 16 bills introduced in just two months, suggesting that regulatory momentum is building rather than plateauing. This legislative activity reflects broader skepticism about private equity ownership models in essential healthcare services, where financial optimization pressures may conflict with continuity of care and affordability objectives. The breadth of coverage—spanning 25 states with multiple bills per state in many cases—indicates that healthcare private equity regulation has transitioned from isolated initiatives to a coordinated policy focus across state legislatures.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.